Loading...
XJPX
7701
Market cap7.12bUSD
Jul 10, Last price  
4,140.00JPY
1D
3.50%
1Q
9.12%
Jan 2017
122.34%
Name

Shimadzu Corp

Chart & Performance

D1W1MN
XJPX:7701 chart
P/E
19.77
P/S
2.13
EPS
209.38
Div Yield, %
1.58%
Shrs. gr., 5y
-0.39%
Rev. gr., 5y
7.34%
Revenues
560.73b
+4.02%
262,431,000,000289,971,000,000272,833,000,000238,255,000,000252,707,000,000266,255,000,000264,048,000,000307,532,000,000314,702,000,000342,236,000,000342,479,000,000376,530,000,000391,213,000,000385,443,000,000393,499,000,000428,175,000,000482,240,000,000511,895,000,000539,047,000,000560,728,000,000
Net income
60.50b
+12.50%
13,379,000,00013,724,000,0008,536,000,0006,130,000,00010,046,000,0009,083,000,0007,578,000,0009,724,000,00018,445,000,00023,899,000,00026,473,000,00029,838,000,00032,524,000,00031,765,000,00036,097,000,00047,289,000,00052,048,000,00057,037,000,00053,775,000,00060,498,000,000
CFO
54.68b
+5.15%
13,990,000,00019,202,000,00012,923,000,00013,756,000,00024,992,000,0008,805,000,00012,028,000,000-5,870,000,00040,245,000,00032,348,000,00029,608,000,00041,215,000,00029,454,000,00039,509,000,00063,801,000,00063,367,000,00048,303,000,00030,127,000,00052,002,000,00054,679,000,000
Dividend
Sep 29, 202627 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Shimadzu Corporation, established in Kyoto, Japan, in 1875, is a global enterprise recognized for its extensive range of cutting-edge instruments and machinery. The company's primary business activities are segmented across several key technological domains. Its analytical and measuring instrument division offers a comprehensive suite of products. This includes various chromatography and mass spectrometry systems (both gas and liquid), advanced tools for molecular and elemental analysis, surface analysis equipment, and essential instruments for life science laboratories. Additionally, they provide solutions for total organic carbon analysis, continuous process monitoring, thermal and particle size analysis, materials testing and inspection, non-destructive testing, and precision balances, all integrated with robust data management and software. In the medical systems sector, Shimadzu delivers state-of-the-art diagnostic imaging technologies. Their offerings span angiography and fluoroscopy systems, mobile C-arms, various radiography and X-ray systems (including mobile units), and fluorescence imaging products. Beyond medical, the company also manufactures high-precision optical and vacuum components, such as diffraction gratings, aspherical mirrors, laser mirrors, polka-dot beam splitters, and precision refractometers, alongside industrial vacuum equipment like turbo molecular pumps, helium leak detectors, sputtering and multi-deposition systems, and vacuum heat-treatment furnaces. Shimadzu's industrial machinery portfolio is diverse, featuring liquid delivery gear pumps, mechatronic systems like glass fiber winders and liquid crystal injection systems, and dynamic balancing machines. They also supply specialized hydraulic equipment, including hydraulic gear pumps, power packages, and multi-control valves. Lastly, the company contributes to the aerospace industry by producing critical aircraft equipment, such as electro-mechanical actuators, sophisticated flight control systems, and landing gear systems.
IPO date
May 16, 1949
Employees
13,898
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT